Mid-Morning Market Update: Markets Open Higher; Nvidia Reports $40B Deal To Buy SoftBank's Arm Holdings

Following the market opening Monday, the Dow traded up 1.40% to 28052.12 while the NASDAQ rose 2.31% to 11104.34. The S&P also rose, gaining 1.77% to 3,400.27.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 6,520,600 cases with around 194,080 deaths. India confirmed a total of at least 4,846,420 confirmed cases and 79,720 deaths, while Brazil reported over 4,330,450 COVID-19 cases with 131,620 deaths. In total, there were at least 29,019,630 cases of COVID-19 worldwide with over 924,460 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Information technology shares climbed 2.4% on Monday. Meanwhile, top gainers in the sector included Priority Technology Holdings, Inc. PRTH, up 24%, and Kingsoft Cloud Holdings Limited KC, up 14%.

In trading on Monday, energy shares rose by just 0.2%.

Top Headline

NVIDIA Corporation NVDA announced plans to acquire British chipmaker Arm Ltd from SoftBank Group’s Vision Fund, in a deal valued at $40 billion.

Under the deal, the Santa Clara, California-based company will fund the purchase of all of Arm’s shares in $12 billion cash and $21.5 billion in stock. $2 billion in cash would be payable at signing of the agreement, Nvidia said in a statement.


Equities Trading UP

Immunomedics, Inc. IMMU shares shot up 101% to $85.00. Gilead Sciences, Inc. GILD announced plans to acquire Immunomedics in a deal at $21 billion.

Shares of Cassava Sciences, Inc. SAVA got a boost, shooting 86% to $6.18 after the company announced results for a Phase 2b clinical study of Sumifilam in patients with Alzheimer's disease showed statistically significant improvements in biomarkers compared to placebo.

Scientific Games Corporation SGMS shares were also up, gaining 41% to $26.76 after the company announced new institutional investors would take a stake in the company at $28 per share. Shares are being purchased from current shareholders.


Equities Trading DOWN

Kala Pharmaceuticals, Inc. KALA shares tumbled 11% to $7.83. Jefferies downgrades Kala Pharmaceuticals from Buy to Hold and lowered the price target from $21 to $10.

Shares of Nano-X Imaging Ltd. NNOX were down 10% to $57.72 after climbing 33% on Friday. Nano X Imaging recently announced it has signed an agreement with SPI Medical for the deployment of 630 Nanox.ARC units in Mexico.

Groupon, Inc. GRPN was down, falling 10% to $29.25 as a potential sell-off following the stock increasing roughly 45% in the last month.

Commodities


In commodity news, oil traded down 0.8% to $37.05, while gold traded up 0.2% to $1,950.80.

Silver traded up 0.6% Monday to $27.02, while copper rose 0.1% to $3.0395.


Euro zone


European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.1%, the Spanish Ibex Index fell 0.1%, while Italy’s FTSE MIB Index fell 0.4%. Meanwhile, the German DAX 30 declined 0.1%, French CAC 40 rose 0.1% and London’s FTSE 100 fell 0.3%.

Eurozone reported that its industrial production climbed better-than-expected by 4.1% in July, versus analysts’ estimates of a 4% increase.


Economics

U.S. consumer inflation expectations report for August will be released at 11:00 a.m. ET.

The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

Market News and Data brought to you by Benzinga APIs
Posted In: M&ANewsPenny StocksEurozoneCommoditiesGlobalIntraday UpdateMarketsMid-Morning Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...